Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

MDGL holding history

Madrigal Pharmaceuticals, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MDGL overviewAll 13F holders of MDGLFull Q2 2026 holdings

Shares (Q2 2026)
1,076
Value
$577.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of MDGL by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,076$577.8K<0.1%+241+28.9%AddedHolders
Q1 2026835$437.1K<0.1%+394+89.3%AddedHolders
Q4 2025441$256.8K<0.1%+53+13.7%AddedHolders
Q3 2025388$178.0K<0.1%+1+0.3%AddedHolders
Q2 2025387$117.1K<0.1%−127−24.7%ReducedHolders
Q1 2025514$170.3K<0.1%+23+4.7%AddedHolders
Q4 2024491$151.5K<0.1%−72−12.8%ReducedHolders
Q3 2024563$119.5K<0.1%−229−28.9%ReducedHolders
Q2 2024792$221.9K<0.1%+58+7.9%AddedHolders
Q1 2024734$196.0K<0.1%−659−47.3%ReducedHolders
Q4 20231,393$322.3K<0.1%−854−38.0%ReducedHolders
Q3 20232,247$328.2K<0.1%−167−6.9%ReducedHolders
Q2 20232,414$557.6K<0.1%+493+25.7%AddedHolders
Q1 20231,921$465.4K<0.1%+1,421+284.2%AddedHolders
Q4 2022500$145.1K<0.1%+142+39.7%AddedHolders
Q3 2022358$23.0K<0.1%+202+129.5%AddedHolders
Q2 2022156$11.0K<0.1%−194−55.4%ReducedHolders
Q1 2022350$34.0K<0.1%+37+11.8%AddedHolders
Q4 2021313$27.0K<0.1%+287+1,103.8%AddedHolders
Q3 202126$2.00K<0.1%−79−75.2%ReducedHolders
Q2 2021105$10.0K<0.1%−8−7.1%ReducedHolders
Q1 2021113$13.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.